Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | INJECTABLE;INTRAVENOUS | 50MG/10ML (5MG/ML) | 0 | OXALIPLATIN | OXALIPLATIN |
002 | INJECTABLE;INTRAVENOUS | 100MG/20ML (5MG/ML) | 0 | OXALIPLATIN | OXALIPLATIN |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2018-03-05 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AP |
002 | Prescription | AP |
CDER Filings
ACTAVIS LLC
cder:Array
(
[0] => Array
(
[ApplNo] => 204880
[companyName] => ACTAVIS LLC
[docInserts] => ["",""]
[products] => [{"drugName":"OXALIPLATIN","activeIngredients":"OXALIPLATIN","strength":"50MG\/10ML (5MG\/ML)","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OXALIPLATIN","activeIngredients":"OXALIPLATIN","strength":"100MG\/20ML (5MG\/ML)","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"03\/05\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2018-03-05
)
)